Effect of Ursodeoxycholic Acid (USDA) on Indirect
Hyperbilirubinemia in Neonates Treated with
Phototherapy
Volume 2 - Issue 3
Mehrdad Mirzarahimi, Manouchehr Barak*, Shima Sarfarazi Moghaddam and Efsaneh Enteshari Moghaddam
-
Author Information
Open or Close
- Department of Pediatrics, Faculty of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran
*Corresponding author:
Manouchehr Barak, Ardabil University of Medical Sciences, Ardabil, Iran
Received: April 29, 2019 Published: May 07, 2019
DOI: 10.32474/PAPN.2019.02.000136
Full Text
PDF
To view the Full Article Peer-reviewed Article PDF
Abstract
Objective: To investigate the effect of USDA in the treatment of indirect hyperbilirubinemia of neonates. Study design: This
randomized clinical trial was conducted on neonates with indirect hyperbilirubinemia whom were hospitalized at Ardabil city
hospital. 100 newborns were enrolled in the study and randomly divided into two groups. The treatment group (n=50) received
10 mg/kg/day divided q12h USDA in addition to phototherapy, while the control group (n=50) only received phototherapy. Total
bilirubin levels were measured every 12 hours until reaching bilirubin below 10mg/dL. Also, duration of phototherapy and
hospitalization in both groups were recorded. Data were analyzed in SPSS.21 using statistical methods.
Results: There was no difference in the mean of total bilirubin between treatment and control groups at baseline, 12, 24, 36,
and 48 hours after admission.
Conclusions: Our study revealed that adding USDA to phototherapy in treating indirect hyperbilirubinemia of newborns had
no preference to just phototherapy treatment.
Keywords: Phototherapy; Indirect Hyperbilirubinemia; Ursodeoxycholic Acid; Neonate
Abstract|
Introduction|
Materials and Methods|
Results|
Discussion|
Conclusion|
Acknowledgment|
References|